Low‐dose interleukin‐2 for the treatment of systemic lupus erythematosus with recurrent rash

Documenti analoghi

• Integrated analysis of lncRNAs expression profiling in systemic lupus erythematosus
  di: Fen Zhang, et al.
  Pubblicazione: (2024)
• Mitochondrial aberrations in systemic lupus erythematosus pathogenesis: Insights and therapeutic implications
  di: Haoguang Li, et al.
  Pubblicazione: (2024)
• Assessing the causality of interferon‐γ and its receptor 1/2 with systemic lupus erythematosus risk using genetic data
  di: Minjing Chang, et al.
  Pubblicazione: (2024)
• Systemic lupus erythematosus presenting with homonymous hemianopia
  di: Aliasghar Ebrahimi, et al.
  Pubblicazione: (2024)
• Treatment strategy for systemic lupus erythematosus using belimumab as indicated by multi‐omics analysis
  di: Keishi Fujio, et al.
  Pubblicazione: (2025)